EBV vax tipped to prevent 200,000 cancer cases; Portuguese regulators suspend use of GSK vaccine;

> Cancer Research UK researchers think a vaccine for the Epstein-Barr virus could prevent up to 200,000 cases of cancer a year. Post

> Portuguese regulators have suspended use of a GlaxoSmithKline ($GSK) vaccine following adverse events. Article

> Pfizer ($PFE) has shown off the Russian production plant that positions it to win government Prevnar contracts. Feature

> A pilot study suggests Merck's ($MRK) shingles vaccine is safe for people with mild lupus. Research

> Sanofi ($SNY) expects Phase III data on its dengue vaccine by late September. News

> Valneva is continuing a Phase II/III of its Pseudomonas aeruginosa vaccine following an interim review. Release

> Australian researchers have talked up their preclinical DNA vaccines against HIV and hepatitis C. Article

> Academics in Texas are working on a vaccine against Escherichia coli but warn it is years away from Phase I. Piece

> CAP-CMV has raised $2.3 million for development of its human cytomegalovirus vaccine candidate. Item

> Unicef and WHO have donated cold chain equipment to areas of the Philippines affected by Typhoon Yolanda. News


Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.